These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

139 related articles for article (PubMed ID: 4305396)

  • 41. Isolation of variants during passage of a strain of foot-and-mouth disease virus in partly immunized cattle.
    Hyslop NS; Fagg RH
    J Hyg (Lond); 1965 Sep; 63(3):357-68. PubMed ID: 4283920
    [No Abstract]   [Full Text] [Related]  

  • 42. Nature of the antibody response to the foot-and-mouth disease virus particle, its 12S protein subunit and the isolated immunizing polypeptide VP1.
    Cartwright B; Morrell DJ; Brown F
    J Gen Virol; 1982 Dec; 63(2):375-81. PubMed ID: 6296284
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Chimeric polioviruses that include sequences derived from two independent antigenic sites of foot-and-mouth disease virus (FMDV) induce neutralizing antibodies against FMDV in guinea pigs.
    Kitson JD; Burke KL; Pullen LA; Belsham GJ; Almond JW
    J Virol; 1991 Jun; 65(6):3068-75. PubMed ID: 1709696
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Immunochemical studies of foot-and-mouh disease. IX. Differences in neutralizing activities of guinea pig and bovine 19S and 7S antibodies.
    Wagner GG; Cown KM
    J Immunol; 1971 Mar; 106(3):656-60. PubMed ID: 4323129
    [No Abstract]   [Full Text] [Related]  

  • 45. Immune and antibody responses to an isolated capsid protein of foot-and-mouth disease virus.
    Bachrach HL; Moore DM; McKercher PD; Polatnick J
    J Immunol; 1975 Dec; 115(6):1636-41. PubMed ID: 171309
    [TBL] [Abstract][Full Text] [Related]  

  • 46. The effect of antiserum quality on strain specificity assessment of foot and mouth disease virus by the neutralization reaction.
    Rweyemamu MM; Ouldridge EJ; Head M; Ferrari R
    J Biol Stand; 1984 Jul; 12(3):295-303. PubMed ID: 6090465
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Detection of foot-and-mouth disease virus antibodies. I. "Passive" hemagglutination test.
    Tokuda G; Warrington RE
    Appl Microbiol; 1970 Jul; 20(1):35-9. PubMed ID: 4318573
    [TBL] [Abstract][Full Text] [Related]  

  • 48. [Effects of gamma radiation on the infectivity, antigenicity and immunogenicity of the foot-and-mouth disease virus].
    Frescura T; Massa D; Cardaras P
    Boll Ist Sieroter Milan; 1972; 51(2):109-17. PubMed ID: 4345590
    [No Abstract]   [Full Text] [Related]  

  • 49. An evalutation of some methods of assay of foot-and-mouth disease antigen for vaccines.
    Garland AJ; Mowat GN; Fletton B
    Dev Biol Stand; 1976; 35():323-32. PubMed ID: 198302
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Neutralization of foot-and-mouth disease virus. I. Sensitization of the 140S virion by antibody also reactive with the 12S protein subunit.
    Hardy MM; Moore DM
    J Gen Virol; 1981 Aug; 55(Pt 2):415-27. PubMed ID: 6169797
    [TBL] [Abstract][Full Text] [Related]  

  • 51. [Viral particle specific serums, used in complement fixation tests of foot-and-mouth disease virus].
    Roumiantzeff M; Fayet MT
    Ann Inst Pasteur (Paris); 1969 Jun; 116(6):833-51. PubMed ID: 4312138
    [No Abstract]   [Full Text] [Related]  

  • 52. Neutralizing antibodies to all seven serotypes of foot-and-mouth disease virus elicited by synthetic peptides.
    Francis MJ; Hastings GZ; Clarke BE; Brown AL; Beddell CR; Rowlands DJ; Brown F
    Immunology; 1990 Feb; 69(2):171-6. PubMed ID: 2155177
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Immunogenicity of foot-and-mouth disease virus type O1 replicated in either monolayer or suspended BHK cell system.
    Gametchu B; Morgan DO; McKercher PD; Scott FW
    Comp Immunol Microbiol Infect Dis; 1983; 6(1):19-29. PubMed ID: 6297845
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Effect of methyl glyoxal on infectivity and antigenicity of foot-and-mouth disease virus.
    Ghizatullina NK
    Acta Virol; 1976 Oct; 20(5):380-6. PubMed ID: 11665
    [TBL] [Abstract][Full Text] [Related]  

  • 55. [Foot-and-mouth disease in buffaloes (Bubalus bubalis, Linnaeus, 1758): search of antiantigen antibodies and isolation of the virus].
    Jerez JA; Pinto AA; Arruda NV; Koseki I; Abuhab TG; Rodrigues MA
    Arq Inst Biol (Sao Paulo); 1979; 46(3-4):111-5. PubMed ID: 233417
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Stability of purified foot and mouth disease virus after freeze-drying and storage.
    Fellowes ON
    Cryobiology; 1968; 5(3):234-7. PubMed ID: 4304872
    [No Abstract]   [Full Text] [Related]  

  • 57. Guinea pig protection test as indicator of potency of oil emulsion foot-and-mouth disease vaccines.
    Black L; Pullen L; Boge A
    Res Vet Sci; 1985 Sep; 39(2):207-11. PubMed ID: 2999930
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Complement-fixation analysis of four subtypes of foot-and-mouth disease virus type A.
    Lobo CA; Cowan KM; Hanson RP
    Appl Microbiol; 1973 Oct; 26(4):570-3. PubMed ID: 4356470
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Immunogenicity of an aphthovirus chimera of the glycoprotein of vesicular stomatitis virus.
    Grigera PR; Garcia-Briones M; Periolo O; la Torre JL; Wagner RR
    J Virol; 1996 Dec; 70(12):8492-501. PubMed ID: 8970972
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Antibody response against foot and mouth disease virus (FMDV). Part II: Responses measured in fractionated sera of infected steers with complete virus, trypsin treated virus, 12 S virus subunits, VIA and heterologous virus.
    Meloen RH
    Zentralbl Veterinarmed B; 1979 Jul; 26(5):358-65. PubMed ID: 93833
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.